Geode Capital Management
PLSE icon

Geode Capital Management’s Pulse Biosciences PLSE Stock Holding History

Geode Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6M Buy
491,946
+27,332
+6% +$504K ﹤0.01% 2344
2025
Q4 		$6.38M Sell
464,614
-4,875
-1% -$76K ﹤0.01% 2641
2025
Q3 		$8.31M Sell
469,489
-29,975
-6% -$474K ﹤0.01% 2519
2025
Q2 		$7.54M Buy
499,464
+33,744
+7% +$560K ﹤0.01% 2520
2025
Q1 		$7.5M Buy
465,720
+4,952
+1% +$92.3K ﹤0.01% 2458
2024
Q4 		$8.02M Buy
460,768
+3,603
+0.8% +$63.5K ﹤0.01% 2496
2024
Q3 		$8.02M Buy
457,165
+33,200
+8% +$566K ﹤0.01% 2499
2024
Q2 		$4.75M Buy
423,965
+33,006
+8% +$311K ﹤0.01% 2757
2024
Q1 		$3.41M Buy
390,959
+11,700
+3% +$108K ﹤0.01% 2892
2023
Q4 		$4.64M Buy
379,259
+25,174
+7% +$174K ﹤0.01% 2739
2023
Q3 		$1.43M Buy
354,085
+45,572
+15% +$283K ﹤0.01% 3189
2023
Q2 		$2.22M Buy
308,513
+166,023
+117% +$1.06M ﹤0.01% 3079
2023
Q1 		$479K Buy
142,490
+2,933
+2% +$8.85K ﹤0.01% 3661
2022
Q4 		$386K Buy
139,557
+6,388
+5% +$14.3K ﹤0.01% 3793
2022
Q3 		$306K Hold
133,169
– – ﹤0.01% 3978
2022
Q2 		$203K Sell
133,169
-119,894
-47% -$301K ﹤0.01% 4254
2022
Q1 		$1.23M Buy
253,063
+5,088
+2% +$41.6K ﹤0.01% 3518
2021
Q4 		$3.67M Buy
247,975
+96
+0% +$1.91K ﹤0.01% 3066
2021
Q3 		$5.35M Buy
247,879
+6,764
+3% +$146K ﹤0.01% 2873
2021
Q2 		$3.95M Buy
241,115
+5,222
+2% +$99.4K ﹤0.01% 3041
2021
Q1 		$5.58M Buy
235,893
+27,127
+13% +$811K ﹤0.01% 2740
2020
Q4 		$4.98M Buy
208,766
+10,443
+5% +$166K ﹤0.01% 2606
2020
Q3 		$2.34M Sell
198,323
-1,734
-0.9% -$18.7K ﹤0.01% 2795
2020
Q2 		$2.09M Buy
200,057
+34,346
+21% +$309K ﹤0.01% 2814
2020
Q1 		$1.19M Buy
165,711
+10,518
+7% +$109K ﹤0.01% 2942
2019
Q4 		$2.08M Buy
155,193
+2,283
+1% +$32.5K ﹤0.01% 2982
2019
Q3 		$2.36M Buy
152,910
+2,325
+2% +$30.2K ﹤0.01% 2843
2019
Q2 		$1.99M Buy
150,585
+16,052
+12% +$219K ﹤0.01% 2958
2019
Q1 		$2.37M Buy
134,533
+17,384
+15% +$273K ﹤0.01% 2755
2018
Q4 		$1.34M Buy
117,149
+38,763
+49% +$469K ﹤0.01% 2977
2018
Q3 		$1.11M Buy
78,386
+7,962
+11% +$113K ﹤0.01% 3176
2018
Q2 		$1.07M Buy
70,424
+8,884
+14% +$150K ﹤0.01% 3159
2018
Q1 		$832K Buy
61,540
+908
+1% +$17.2K ﹤0.01% 3205
2017
Q4 		$1.43M Buy
60,632
+1,381
+2% +$32.6K ﹤0.01% 2945
2017
Q3 		$1.1M Buy
59,251
+1,336
+2% +$30.3K ﹤0.01% 3079
2017
Q2 		$2M Buy
57,915
+15,459
+36% +$425K ﹤0.01% 2732
2017
Q1 		$866K Buy
42,456
+13,910
+49% +$189K ﹤0.01% 3089
2016
Q4 		$185K Hold
28,546
– – ﹤0.01% 3643
2016
Q3 		$179K Buy
+28,546
New +$146K ﹤0.01% 3644

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management's PLSE Position: Q1 2026 in Review

Geode Capital Management increased its Pulse Biosciences (PLSE) stake by 5.9% in Q1 2026, buying an estimated $504K and bringing the position to 491,946 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2344.

Geode Capital Management first reported a position in PLSE in Q3 2016 and has held it in 39 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Geode Capital Management held 491,946 shares of Pulse Biosciences worth $10.6M as of Q1 2026.
  • Geode Capital Management bought 27,332 Pulse Biosciences shares in Q1 2026, an estimated $504K.
  • Pulse Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2344 holding.
  • Geode Capital Management first reported a position in Pulse Biosciences in Q3 2016 and has held it in 39 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.